Potential salvage therapy for accidental intrathecal vincristine administration:: A preliminary experimental study

被引:6
作者
Özgen, Ü
Soylu, H
Önal, SÇ
Mizrak, B
Türköz, Y
Kutlu, NO
Koçak, A
Özcan, C
Koltuksuz, U
Erten, SF
Akçin, Ü
机构
[1] Inonu Univ, Turgut Ozal Med Ctr, Dept Pediat, Malatya, Turkey
[2] Inonu Univ, Turgut Ozal Med Ctr, Dept Neurosurg, Malatya, Turkey
[3] Inonu Univ, Turgut Ozal Med Ctr, Dept Pathol, Malatya, Turkey
[4] Inonu Univ, Turgut Ozal Med Ctr, Dept Biochem, Malatya, Turkey
[5] Inonu Univ, Turgut Ozal Med Ctr, Dept Neurol, Malatya, Turkey
[6] Inonu Univ, Turgut Ozal Med Ctr, Dept Pediat Surg, Malatya, Turkey
关键词
intrathecal vincristine; HOCl; neurotoxicity; brain; rabbits;
D O I
10.1159/000007305
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Accidental intrathecal vincristine (VCR) administration results in severe neurotoxicity, usually fatal in outcome. No specific therapy for initrathecal VCR toxicity has been reported so far. In our recent report, complete in vitro degradation of VCR by hypochlorous acid (HOCl) was demonstrated. Methods: In this comparative study, we examined the in vivo effectivity of HOCl in the cerebrospinal fluid of 24 New Zealand rabbits following intracisternal VCR administration. Results: There were no significant clinical or histopathologic abnormalities in the control and HOCl groups; however, multiple necrotic foci on histopathological examination of brain sections in the VCR group were determined. There were significantly lower numbers of necrotic foci in brain sections of rabbits which received HOCl administration than those without therapy. Conclusion: Our results indicate that HOCl may reduce VCR neurotoxicity. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:322 / 326
页数:5
相关论文
共 12 条
[1]  
DYKE RW, 1989, NEW ENGL J MED, V321, P1270
[2]  
GAIDYS WG, 1983, CANCER, V52, P799, DOI 10.1002/1097-0142(19830901)52:5<799::AID-CNCR2820520508>3.0.CO
[3]  
2-Z
[4]   AMELIORATION OF VINCRISTINE NEUROTOXICITY BY GLUTAMIC-ACID [J].
JACKSON, DV ;
WELLS, HB ;
ATKINS, JN ;
ZEKAN, PJ ;
WHITE, DR ;
RICHARDS, F ;
CRUZ, JM ;
MUSS, HB .
AMERICAN JOURNAL OF MEDICINE, 1988, 84 (06) :1016-1022
[5]   ACCIDENTAL INTRATHECAL VINCRISTINE ADMINISTRATION - REPORT OF A CASE [J].
MANELIS, J ;
FREUNDLICH, E ;
EZEKIEL, E ;
DORON, J .
JOURNAL OF NEUROLOGY, 1982, 228 (03) :209-213
[6]   Fatality resulting from intraventricular vincristine administration [J].
Meggs, WJ ;
Hoffman, RS .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1998, 36 (03) :243-246
[7]   Potential salvage therapy for inadvertent intrathecal administration of vincristine [J].
Michelagnoli, MP ;
Bailey, CC ;
Wilson, I ;
Livingston, J ;
Kinsey, SE .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :364-367
[8]   Further elucidation of mechanism of resistance to vincristine in myeloid cells:: role of hypochlorous acid in degradation of vincristine by myeloperoxidase [J].
Özgen, Ü ;
Savasan, S ;
Stout, M ;
Buck, S ;
Ravindranath, Y .
LEUKEMIA, 2000, 14 (01) :47-51
[9]   FATAL MYELOENCEPHALOPATHY CAUSED BY INTRATHECAL VINCRISTINE [J].
SLYTER, H ;
LIWNICZ, B ;
HERRICK, MK ;
MASON, R .
NEUROLOGY, 1980, 30 (08) :867-871
[10]  
WILLIAMS ME, 1983, CANCER, V51, P2041, DOI 10.1002/1097-0142(19830601)51:11<2041::AID-CNCR2820511114>3.0.CO